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Abstract
Low back pain (LBP) is the most common orthopedic complaint managed by
physical therapists in the United States. Insurance plans that require greater patient
financial liability per physical therapy visit are thought to disincentivize participation in
recommended physical therapy plans of care. The primary purpose of this investigation
was to use instrumental variable regression to investigate the effect of insurancemediated patient financial liability per visit on physical therapy visit count and functional
patient reported outcomes. The secondary purpose of the study was to examine the
generalizability of results to the broader excluded patient population—and beyond to
patients that seek physical therapy for LBP. Insurance-mediated patient financial liability
per visit was a poor instrument with an inconsistent effect that trended against the
hypothesized direction. The instrument had no statistically or clinically important effect
on visit count, and no subsequent clinically important change in patient reported
outcome. A comparison of baseline patient information and “index” values for predicted
visit count and change in patient reported outcome identified few potential clinically
important differences, yielding the conclusion that results of the primary investigation are
likely generalizable to a broader patient population with LBP. These results suggest
patient financial liability per visit is a poor instrument with currently available data;
however, any results from large observational analyses would likely generalize to a larger
patient population with LBP.
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Chapter 1
Introduction & Review of Literature
Background
Low back pain (LBP) is the most common orthopedic complaint in the United
States (U.S.) with an estimated lifetime prevalence of 80%.1 Evidence-based guideline
care recommendations have been introduced to promote clinically and cost-effective
management—and reduce costly, unwarranted variation in the evaluation and
management of patients seeking medical care for LBP.2,3 Early care guidelines coendorsed by the American College of Physicians and the American Pain Society in 2007
promoted screening for psychological risk-factors known to influence the development of
chronic LBP and a thorough physical exam that categorized patients into defined
classification groups to help guide appropriate interventions.2 These guidelines also
strongly endorsed limited use of imaging (i.e., x-rays, computed tomography [CT], and
magnetic resonance imaging [MRI]), limited use of over the counter medication (i.e.,
acetaminophen, non-steroidal anti-inflammatory drugs [NSAIDS]), and promoted patient
education that encouraged appropriate self-care, maintaining an active lifestyle, and an
understanding of the expected course of their condition.2 More recently, guideline
recommendations co-endorsed by the American College of Physicians and American
Academy of Family Physicians in 2017 recommended classifying patients as
acute/subacute or chronic—then provided evidence-based, non-invasive treatment
recommendations for each classification.3 For patients with acute or subacute LBP,
1

superficial heat, massage, acupuncture, spinal manipulation, NSAIDS, and skeletal
muscle relaxants were recommended; while exercise, multidisciplinary rehabilitation,
acupuncture, mindfulness, Tai Chi, yoga, motor control exercise, progressive relaxation,
electromyography biofeedback, low-level laser therapy, cognitive behavioral therapy,
spinal manipulation, limited use of NSAIDS and prescription drugs such as Tramadol and
Duloxetine, and prescription opioids as a last resort were recommended for patients with
chronic LBP.3 While providers are not expected to apply or recommend all described
intervention strategies, they are expected to routinely incorporate these evidence-based
care approaches for their patients with LBP.
Knowledge Gap
These care recommendations are routinely applied in the physical therapy
settings.4 However, there are mixed results when examining health outcomes in patients
receiving treatment from these ancillary health providers.5-15 Heterogeneity of treatment
effect related to patients’ attitudes, beliefs, willingness to participate in and pay for
healthcare, and predisposition to respond to care likely contribute to these muted
effects—but differences in clinical effectiveness and expertise of the providers may also
contribute.16-20
Patient reported outcomes (PROs) are commonly used as the primary health
outcome in orthopaedic physical therapy clinical and research settings.16,17,21-33 In
research settings, it is important to consider how a PRO is used. Comparative
effectiveness researchers typically opt to examine change in the PRO from the index date
(i.e. initial date of complaint) through final evaluation.34 Other potential options include
identification of a PRO “cut score” that equates to “success” or “failure” or using the
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final or discharge PRO as a numeric outcome. PROs provide the healthcare provider and
researcher with valuable information regarding patient perception of their health
condition, and the effect of treatment on their function and/or health status.35
Many PROs are used for the management and study of patients with LBP.
Commonly used PROs for patients with LBP include the Oswestry Disability Index
(ODI) and its modification—the Modified Low Back Pain Disability Questionnaire
(MDQ), Roland-Morris Disability Questionnaire (RMDQ), and Quebec Back Pain
Disability Scale (QBPDS).22,36-38 The ODI and its modification, the MDQ, represent the
most commonly used PROs for patients with LBP in the outpatient physical therapy
setting.32 ATI Physical Therapy utilizes the MDQ and represents the primary data source
for this investigation (detailed below); therefore, greater detail specific to the MDQ
follows. The MDQ is a functional status, condition-specific PRO for patients with LBP
that consists of 10 questions.22,39 Responses range from 0 (no disability) to 5 (maximal
disability) for each question yielding a total of 50 potential “raw” points (higher score =
greater disability).22 This value is then doubled to identify a “percent disability” related to
the lower back for a patient. Pertinent statistical properties of the MDQ to consider
include standard error of the measure (SEM), minimal detectable change (MDC),
minimal clinically important difference (MCID), Cronbach’s alpha, and intraclass
correlation coefficient (ICC). As the MDQ is a modified version of the original ODI, few
studies have examined its statistical properties separately from the original ODI. Fritz and
Irrgang22 reported an SEM of 5.4, MDC of 12.7, MCID of 6, and ICC of 0.9 specific to
the MDQ, while more recent work identified an MCID of 10.8.40 While one conditionspecific (i.e., pelvic girdle pain) study examined Cronbach’s alpha for the MDQ, none

3

have reported these values in a general population with LBP.41 Fritz and Irrgang22
concluded that the MDQ had better measurement properties than the QBPDS. Resnik and
Dobrzykowski24 identified comparable statistical properties for the ODI and its
modifications (including MDQ) and the RMDQ and concluded that either are reasonable
for use in outcomes research involving patients with LBP.
It has been demonstrated that change in MDQ is influenced by initial MDQ,
initial Veteran’s RAND 12-Item Health Survey (VR-12) Mental (MCS) and Physical
(PCS) component scores, age, sex, body mass index (BMI), comorbid conditions reported
on a baseline health history, state of physical therapy services, payer status, status as
chronic condition, and ZIP-level median income.16,22,42 The VR-12 is a general health
survey with both mental and physical component scores as highlighted above.43 It is a
norm-based standardized outcome that allows the investigator to control for health status
relative to a population-based distribution for each component scoer.42 While not specific
to change in MDQ, baseline objective clinical measures, exercise history, surgical
history, specific diagnoses, clinical presentation (i.e., LBP with pain below knee), clinic
level characteristics (e.g., referral source, number of referrals), employment status,
provider equipoise, patient and provider beliefs and preferences, and fear-avoidance have
also been identified or theorized as factors that influence change in PROs.15,17,25,27-29,44
Finally, it is theorized that the number of physical therapy visits attended relative to a
hypothetical ‘optimal’ amount has an influence on PRO change. Figure 1.1 highlights
these factors known or theorized to influence PRO change.
While the number of physical therapy visits attended is a factor theorized to
influence PRO change, it is also an outcome—with several factors known or theorized to

4

influence its utilization. As an outcome, it offers the investigator flexibility in research
design, opportunities to perform multiple comparisons to corroborate findings, and the
ability to make more accurate assessments of the risks associated with treatment(s).45
Factors known or theorized to influence physical therapy visit count (Figure 1.2) include
initial disability, health insurance generosity or plan generosity, prior health seeking
behaviors, access to care, socioeconomic status, health status, patient and provider
beliefs, surgical history, and provider supply.46-54 While objective, healthcare claims and
utilization information are not captured for research purposes, intended instead for billing
and reimbursement. These data sources can lack detail that would be important to the
researcher and therefore limit the inferences that can be made.55
Healthcare utilization as a health outcome can be used broadly to observe health
trends or with more granularity to provide clinical context and inform policy. Using
healthcare utilization as an outcome is beneficial because it is often associated with large
sample sizes pulled from health system or insurance databases.45 It is also void of patient
factors that can introduce bias such as recall or refusal to participate.56,57 Additionally,
while healthcare utilization is sometimes used as a proxy for health status, there is no
clear association between healthcare utilization and PROs.58 Rundell et al59 explored this
idea peripherally and found that physical therapy service utilization of active and manual
interventions were associated with self-reported pain and there was a threshold for
utilization of these services associated with improved PROs—but there was no linear
relationship between the two. Furthermore, predictors of change in PROs often differ
from predictors of healthcare utilization.16,17,27-29,50 Finally, this relationship is likely
mediated in some way by insurance attributes that affect a patient’s financial liability for
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treatment.21,60 It is reasonable to believe, therefore, that this assumption has limitations
and these relationships should be further investigated.
Theoretical & Methodological Framework
Little is understood regarding the interrelationships between patient factors,
healthcare evaluation and management, patient financial responsibility per physical
therapy visit, and healthcare utilization and PROs. Donabedian61 called health outcomes
the “ultimate validators of the effectiveness and quality of medical care”. Health
outcomes, including PROs, are often missing in these ‘real world’ research designs,
leading investigators to explain away the missingness and its effect on validity and
generalizability.62-64 While problematic for PROs collected prospectively in a controlled
research setting, the challenge of PRO missingness can be magnified when examining
secondarily obtained observational data from electronic health records (EHRs) and health
databases. Patient reported outcomes derived from EHRs are often used in orthopaedic
physical therapy research to test the effectiveness of interventions and
therapists.9,16,17,24,25,27-30,33,34 There is wide variation in collection of follow-up PROs
across the rehabilitation industry, and little is understood regarding the appropriate
handling of these missing outcomes and the impact of missingness on generalizability of
results.16,17,25,27,29,30
Instrumental variable (IV) regression is an observational research approach that
exploits natural variation to allow causal inference.65-67 It utilizes a two-stage least
squares (2SLS) approach in which the first stage regresses all baseline explanatory
variables (i.e., baseline demographic and outcome information) and exogenous IVs to
estimate the treatment choice (i.e., physical therapy visit utilization), and the second stage
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regresses all baseline explanatory variables AND first stage outcome(s) to estimate the
healthcare utilization outcomes defined below.66,67 Estimates derived from IV estimators
can therefore be generalized to a “marginal” subset of patients whose treatment choices
are influenced by the instrument.66
Instrumental Variables are variables theorized to impact treatment choice but
have no impact on the outcome of treatment.67,68 Harris and Remler69 highlight 4
conditions a variable must meet for consideration as a valid instrument. The candidate IV
must: 1) influence probability of treatment, 2) not independently effect change in the
outcome of interest, 3) not be influenced by health status or health outcomes
(exogeneity), and 4) only influence the probability of treatment in one direction
(monotonicity). Health insurance plan-level patient financial liability per visit was
considered as the candidate IV. Health insurance plan generosity was theorized to
influence treatment choice by incentivizing more physical therapy visits. Additionally,
there was no direct theorized influence of insurance plan-level patient financial liability
per visit and PRO change—aside from its effect via visit count. Finally, because it was
aggregated to the insurance level mean, the IV was exogenous to any 1 patient.
Research Questions
1. What is the influence of insurance-level patient financial liability per visit on
physical therapy visits and episodic patient reported outcomes in commercially
and Medicare-insured patients?
The purpose of this investigation was to evaluate the influence of insurancemediated patient financial liability per visit on physical therapy visit count and PRO
change. Commercially-insured patients 18 – 64 years of age that received physical
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therapy for “nonoperative” LBP at ATI Physical Therapy across 26 states in the U.S.
between January 1, 2017 and December 31, 2018 were considered for inclusion.
“Nonoperative” LBP was defined for this Research Question as LBP with no selfreported surgical intervention related to the lumbar spine within 120 days prior to initial
physical therapy evaluation. Baseline patient demographic information, initial and final
MDQ outcomes, health insurance-level patient financial liability per visit, and physical
therapy billing and utilization information for all patients were extracted from the ATI
Physical Therapy Patient Outcomes Registry.
The patient financial liability per physical therapy visit averaged across an
insurance plan was the candidate IV for Research Question 1. While a portion of patients
in this sample may have sought out employment opportunities or an insurance market
insurance plan specifically related to their anticipated musculoskeletal health needs, the
assumption for this investigation is that the vast majority of patients did not select
insurance benefits specific to expected impact on the management of LBP. Further, by
using the aggregated insurance plan-level mean and requiring a minimum patient count
per plan, the patient financial liability per visit was exogenous to any 1 patient in the
insurance plan and observed variation is this metric provided a natural experiment for
testing.
Of the independent variables known or theorized to impact PRO change and
physical therapy visit utilization described above, those measurable in the ATI Physical
Therapy Patient Outcomes Registry were initial MDQ, initial VR-12, sex, age, body mass
index (BMI), time from onset to initial physical therapy evaluation dichotomized as acute
or chronic (>=90 days), patient ZIP-level median annual income as a proxy for
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socioeconomic status (SES), and comorbid conditions per patient-reported medical
history.16,17,27,28,42 The first stage regression equation regressed all independent variables
and the candidate IV on the number of physical therapy visits observed in the episode of
care between initial and final MDQ. The second stage regression equation regressed all
independent variables and the first stage predicted value (i.e., number of physical therapy
visits in the episode of care) on the terminal outcome, MDQ change.
This methodology allows for careful inferences to be made regarding PROs in
marginal patients for whom treatment choice (i.e., number of physical therapy visits) is
affected by patient financial liability per visit. It is hypothesized that these marginal
patients will achieve clinically important benefit (i.e., greater PRO change) for choosing
to attend more physical therapy visits.
Limitations
Limitations to this research approach should be considered. First, data for this
research question was obtained for commercially insured patients from a group of
physical therapy clinics owned by the same company (ATI Physical Therapy).
Accordingly, results may not generalize to other payer types or physical therapy
providers. Second, patient financial liability may not be a strong enough instrument to
significantly influence the number of physical therapy visits a patient attends. While the
study controls for ZIP-level SES, individual SES and specific insurance plan structure
were unknown and likely drive healthcare utilization to a greater extent than is
observable when examining the effects of patient financial liability. Further, recent
evidence suggests that high deductible health insurance plans have a similar effect on
physical therapy utilization as health insurance plans with much lower deductibles.47
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High deductible plans with employer or employee tax deductible savings accounts may
be more willing to take on the risk associated with greater financial liability associated
with their healthcare. The interaction between socioeconomic status and plan design is
also likely a contributing factor as wealthy beneficiaries have been demonstrated to selfselect to high deductible, health savings account-styled plans given their added ability to
take on the associated financial risk.70 Third, the MDQ may be insufficiently
discriminatory as the terminal outcome of interest—yielding results that are not
statistically, or more importantly clinically significant.22,36 Finally, additional unknown
and unmeasured confounding may remain due to the lack of predictability associated with
physical therapy outcomes—leading to biased estimates.16,17,30
Delimitations
Consistent with the stated limitations of the study, the results of this analysis are
generalizable only to commercially-insured patients 18 – 64 years of age with
nonoperative LBP that receive physical therapy for their complaint under the care of a
large, unified physical therapy provider. Furthermore, conclusions only apply to marginal
patients impacted by the patient financial liability for physical therapy visits as dictated
by their insurance policy. Although it is not feasible to directly identify whom these
marginal patients are a priori, precedent comparisons have been made between quintiles
of the instrument and similar representative comparisons will be made in this
investigation.65,71
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2. What is the influence on missingness and loss to follow-up in physical therapy
outcomes research?
Research endeavors often take place in a ‘real world’ environment to improve
available sample and maximize generalizability.16,17,27-29,52,72,73 The United States
Department of Health and Human Services has defined comparative effectiveness
research (CER) as research that compares “the benefits and harms of different
interventions and strategies to prevent, diagnose, treat and monitor health conditions in
“real world” settings.”74 Further, it aims to clarify the effectiveness of established health
interventions.75
Because “real world” health information and pragmatic research approaches often
lack data, we desired to better understand how generalizable the inferences made on the
“complete cases” was to the broader, less complete patient population. As a
representative sample, Research Question 1 required the inclusion of several distinct data
sets, limiting the included sample significantly. The purpose of Research Question 2 was
to thoroughly vet baseline patient information and patient reported outcomes (PROs) to
establish a level of confidence for the generalizability of results to the broader physical
therapy patient population. Available evidence suggests that baseline patient information
accounts for less than 40% of the variability in PRO change. Despite this limitation in
predictive ability, if known baseline information for the included and excluded cohorts of
patients were comparable, our confidence in the generalizability of the results and
inferences would improve.16,17,30 We hypothesized that these baseline values would
indeed be comparable, and the inferences made would generalize well to the broader
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patient population—understanding that limitations remain, given the unexplained
variability.
Limitations
Like the approach for Research Question 1, the data used for this investigation
were observational, secondarily obtained data collected for billing purposes and not
intended to be used for research. While commercially insured patients with LBP
accounted for approximately 55% of the ATI Physical Therapy patient population,
inferences were limited to those payer groups. Finally, as ATI Physical Therapy is a
single, unified company, results may be related to unique proprietary behaviors and a
strict interpretation would generalize only to their patients.
Delimitations
The results of Research Question 2 informed generalizability of Research
Question 1 to the broader commercial-insured patient population—including those that
failed to complete following PROs. Chapters 4 and 5 offer an extended discussion of
delimitations as this is the focus of Research Question 2.
Data Integrity and Security
Data integrity and security was vital and well-maintained throughout the
investigations. A data use agreements (DUA) was in place prior to the transfer of data
between entities. Patient information provided by ATI Physical Therapy was transferred
securely from within the ATI Physical Therapy Health Insurance Portability and
Accountability Act (HIPAA) certified server to the South Carolina Center for
Effectiveness Research in Orthopaedics (SC CEROrtho) HIPAA-certified server using an
existing Secure File Transfer Protocol. All policies and procedures set forth by the DUA

12

were followed. This investigation was approved by the University of South Carolina
Institutional Review Board (Pro00090115).
Conclusion
The two aims fill important gaps in musculoskeletal health and physical therapy
literature. While it is logical that insurance plans with higher patient financial liability
influence patients to attend fewer physical therapy visits—and that those with fewer visits
for the same condition have poorer PROs at discharge, this complex relationship has not
been thoroughly tested. Second, at a time when the clinical quality and effectiveness is
increasingly important with the rise of value-based reimbursement, it was important to
have a better understanding of the importance of missingness and its effect on
generalizability in physical therapy outcomes research.

Figure 1.1: Factors Known or Theorized to Influence PRO Change
13

Figure 1.2: Factors Known or Theorized to Influence Physical Therapy Visit Count
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Chapter 2
Methodology
Research Design: Overview
The overall goal of this study was to evaluate the role of patient financial liability
per visit on patient reported outcomes (PROs) and physical therapy visit utilization.
Research Question 1 used an instrumental variable (IV) regression approach to examine
the influence of insurance-level patient financial liability per visit on physical therapy
utilization and PROs for patients that received care from a single, national physical
therapy provider. Research Question 2 explored the generalizability of results to the
cohort of excluded patients from Research Question 1. Observational research methods
were used in an attempt to fill important gaps in the literature regarding the association
between health insurance plans, physical therapy visit utilization, and PRO change for
patients with low back pain (LBP). Statistical computations were performed using R
within a Health Insurance Portability and Accountability Act (HIPAA) secure server.76
The studies followed the REporting of studies Conducted using Observational Routinely
collected Data initiative and was approved by The University of South Carolina
Institutional Review Board (Pro00090115).77
Research Questions
1. What is the influence of insurance-level patient financial liability per visit on
physical therapy visits and episodic patient reported outcomes in commercially
and Medicare-insured patients?
15

Data Source and Patient Identification
The purpose of this investigation was to better understand the influence of
baseline patient characteristics and health insurance attributes on physical therapy visit
utilization and PRO change. Commercially-insured patients 18 – 64 years of age that
received physical therapy for nonoperative LBP at ATI Physical Therapy across 26 states
in the United States (U.S.) between January 1, 2017 and December 31, 2018 were
considered for inclusion. Commercially-insured patients were the focus of this study for 2
primary reasons. First, they were the most prevalent insurance payer observed in the
database—covering roughly 55% of patients treated for LBP. Second, commercial payers
provided a representative sample with wide variation in policy options with vastly
different payment structures that impact patient financial liability.
Baseline patient demographic information, initial and final Modified Low Back
Pain Disability Questionnaire (MDQ) outcomes, patient financial liability, and physical
therapy billing and utilization information for all patients were extracted from the ATI
Patient Outcomes Registry. Nonoperative LBP was defined for this Research Question as
LBP with no self-reported surgical intervention related to the lumbar spine within 120
days of initial physical therapy evaluation. Because recurrence of LBP is common, all
patient episodes were considered separately. This allowed for a practical and
representative sample of patients commonly treated in physical therapy settings. While
ideally recurrence would have been known and used as a control variable, we were
unable to control for episodes of LBP prior to a patient’s initial start date within ATI
Physical Therapy—nor could we control for any healthcare services for LBP outside of
ATI Physical Therapy.
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Physical Therapy Variables Typically Acquired During Treatment Episode
Demographic, health history, physical therapy visit count, and PRO data acquired
during the typical physical therapy episode of care for patients with LBP were extracted
from the ATI Patient Outcomes Registry, registered with ClinicalTrials.gov
(NCT02285868) and the U.S. Department of Health and Human Services Agency for
Healthcare Research and Quality in the Registry of Patient Registries (2608). An episode
of care was defined as all services rendered from initial physical therapy evaluation
through final observed MDQ in the electronic health record.
Available demographic information included age, sex, body mass index (BMI),
commercial payer attributes (i.e., copayment, deductible and coinsurance), and SES—
using ZIP-level median annual income as a proxy. Baseline disability level was
determined by the initial MDQ score calculated at the initial physical therapy evaluation.
Available health history was patient-reported via medical history form in the form of yesno response to 31 commonly reported health conditions and symptoms, of which each
was considered separately as a covariate. The candidate IV, insurance plan-level patient
financial liability per visit, and number of physical therapy visits from initial to final
MDQ was queried from episode-level information within the ATI Patient Outcomes
Registry. Finally, the change from initial to final MDQ was the terminal outcome of
interest as described below.22,36,78
Variable Utilization
Terminal Outcomes of Interest
The PRO change from initial to final MDQ was considered as the primary
terminal outcome. Change in MDQ offers a validated measure for whom important
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change is well-understood and recognized.22,34,36 Further, it was recently validated as a
performance measure to assess the quality of physical therapy providers.16,30
First-Stage: Variables Theorized to Influence Treatment Choice (Physical Therapy
Visits)
Chapter 1 highlighted all information known or theorized to influence physical
therapy visit and/or utilization and PRO change. Of those listed, the following were
available in the ATI Physical Therapy Patient Outcomes Registry and considered for
inclusion in the first stage regression equation. First, demographic characteristics
associated with physical therapy and/or healthcare utilization including sex, BMI, and
age were obtained.79 Second, patients’ ZIP-level median income was used as a proxy for
socioeconomic status (SES), another patient factor associated with healthcare
utilization.79 Finally, initial disability related to LBP (i.e., initial MDQ), health status
(i.e., initial Veteran’s RAND 12-Item Health Survey [VR-12]), status as chronic
condition, and comorbid conditions were derived as they also have been demonstrated to
influence physical therapy utilization.16,79 While a validated comorbidity measure such as
the Charlson Comorbidity Index was not available within the data, inclusion of a patientreported comorbid health history functioned as a proxy as it has in prior outcomes
research.16,30,80
To address the validity and interpretability concerns of having differing structures
of insurance attributes (i.e., copayment, deductible and coinsurance), average patient
financial liability per physical therapy visit averaged across an insurance plan structure
for a given year was considered as the IV. Patients insured by a health insurance plan
with fewer than 20 patients were excluded from the final analyses. This insurance-level
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value was exogenous to any one patient in the sample as it was derived from a broader
sample of like-insured patients.
Second Stage: Variables Theorized to Influence Outcomes of Interest (Change/Final
MDQ)
All baseline variables (aside from the candidate IV) were included in the Second
Stage regression equation; the First Stage predicted visit count was also included.16,17,2730,34

Demographic characteristics including sex, BMI, and age have been demonstrated to

influence PRO change.16,17,28,29 ZIP-level median income as a proxy for SES has been
demonstrated to significantly influence MDQ change.16 Finally, baseline disability per
initial PRO, baseline health status per VR-12, status as chronic condition, and reported
comorbid conditions have also been demonstrated to influence PRO and MDQ
outcomes.16,17,28,29 Table 2.1 describes variable utilization by regression stage for
Research Question 1.
Testing Assumptions of the Candidate Instrumental Variable
While variation in health insurance attributes such as copayment and deductible
with coinsurance were known or theorized to impact physical therapy utilization
(Condition 1), there was no direct theoretical link from these health insurance attributes
to health outcomes in patients with LBP beyond differences that exist due to variation in
healthcare utilization (Condition 2).51 While the insured may attempt to tailor a plan to
meet their anticipated musculoskeletal healthcare needs, requiring a 20-patient minimum
by plan ensured that the IV was exogenous to any 1 patient (Condition 3). Consistent
with the recommendation of Harris and Remler69 and recent work by Brooks et al65,
baseline information observable at the time of initial evaluation (i.e., initial MDQ and
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VR-12, sex, age, BMI, time from onset to initial physical therapy evaluation
dichotomized as acute or chronic (>90 days), patient ZIP-level median annual income,
and count of comorbid conditions per patient-reported medical history) were compared
after dividing included patients into subsets by the instrumental variable (i.e., quintile).
Finally, it was logically theorized that increasing a patient’s financial burden for
treatment would have a monotonic relationship with the probability of receiving
treatment (Condition 4). In other words, increasing patient financial liability per visit was
only theorized to decrease the likelihood of more physical therapy visits. It was our belief
that patient financial liability met the 4 conditions and was appropriate for use as an
instrument.
Measurement Properties of the Modified Low Back Pain Disability Questionnaire
(MDQ)
The MDQ utilizes a 50-point scale that is converted to a percentage with 0%
indicating absence of disability and 100% indicating complete disability. A minimal
clinically important difference (MCID) of 6 on a 100-point scale has been reported for
the MDQ; while its similar predecessor (Oswestry Disability Index) has a reported MCID
of 10.23,36 Additionally, values for standard error of the measure (SEM), minimal
detectable change (MDC), and intraclass correlation coefficient (ICC) have been reported
at 5.4, 12.7, and 0.9, respectively, for the MDQ.22
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Analytical Approach: Instrumental Variable Regression using Two-Stage Least
Squares
Instrumental Variable estimation using two-stage least squares (2SLS) was used
to better understand the influence of patient financial liability per visit on physical
therapy visit utilization and MDQ change as described above.
First Stage: Estimating Treatment Choice (Physical Therapy Visits)
The first stage of the 2SLS IV approach was used to estimate physical therapy
visit count using all first stage covariates described above (abbreviated Xin with each n
representing 1 of k independent variables) and the IV (abbreviated Zi). A representative
first stage regression equation follows:
Pi= α0+ α1(Xi1) + α2(Xi2) + … + αk(Xik) + αt(Zi) + εi
Where i represents an individual patient and:
·

‘P’ represents physical therapy visits

·

‘Xin’ represents each first stage covariate (for 1 to k included independent
variables)

·

‘Zi’ represents the instrumental variable (actual patient financial liability)

·

‘α0’ represents the intercept

·

‘αn’ represent the coefficients for each covariate (for 1 to k included
independent variables)

·

‘αt’ represents the coefficient for the instrumental variable

·

‘εi’ represents the error
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Second Stage: Estimating MDQ Change
The second stage of the 2SLS IV approach was used to estimate MDQ change
using all second stage covariates described above (abbreviated Xin with each n
representing 1 of k independent variables) and predicted visit count from the first stage
above. Representative second stage regression equations are presented below:
MDQ Changei = β0+ β1(Xi1) + β2(Xi2) + … + βk(Xik) + βt(Pi-hat) + εi
Where i represents an individual patient and:
·

‘Change MDQi’ represents total change from initial to final MDQ score

·

‘P-hat’ represents predicted physical therapy visits from the first stage
regression

·

‘Xi’ represents each covariate

·

‘β 0’ represents the intercept

·

‘βn’ represent the coefficients for each covariate (for 1 to k included
independent variables)

·

‘βt’ represents the coefficient for predicted physical therapy visit count

·

‘εi’ represents the error

Summary: Aim 1 Methods
While many factors are known to impact PROs, this was the first study to explore
the interrelationship between patient financial liability per visit, physical therapy visit
utilization, and PRO change. While it is known that referrals to physical therapy are
impacted by payer type (e.g., commercial, Medicare, Medicaid, Worker’s Compensation)
and plan structure (e.g., Preferred Provider Organization, Health Maintenance
Organization), no study to date has examined the influence of baseline patient
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characteristics, initial PROs, and patient financial liability on physical therapy visit count
and PRO change.47,60,81 The above research approach sought to inform these gaps in the
healthcare outcomes and utilization literature.
2. What is the influence on missingness and loss to follow-up in physical therapy
outcomes research?
Data Source & Patient Identification
The same data sources and patients from Research Question 1 were used for
Research Question 2. The following methods sought to thoroughly compare patients
included in the final analytical cohort to those excluded from the study. The rationale for
this approach was to establish a level of congruency between cohorts of patients to
estimate a level of confidence in the generalizability of the outcomes from Research
Question 1. Figure 3.1 in the Chapter 3 details the flow of inclusion and exclusion from
which comparative cohorts were derived.
Comparison of Baseline Patient Characteristics
Independent samples t-tests compared baseline numeric variables (i.e., age, body
mass index [BMI], Modified Low Back Pain Disability Questionnaire [MDQ], Mental
[MCS] and Physical [PCS] Component Scores of the Veteran’s RAND 12-Item Health
Survey [VR-12], count of comorbid conditions, insurance plan-level patient financial
liability per visit, and census-derived ZIP-level median income) between the included and
excluded cohorts with 95% confidence intervals (CIs) reported as appropriate. Chi-square
analyses tested for differences baseline categorical variables (i.e., sex and condition
present ≥ 90 days at initial evaluation).
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Comparison of Predicted ‘Index’ Values:
The primary investigation used a 2-stage least squares (2SLS) instrumental
variable (IV) regression approach including all baseline patient factors described above to
predict physical therapy visit count in the first stage and change in PRO in the second
stage. In the primary analyses, these models were run using only complete, included
patients. This study sought to identify 2 novel “Index” values aggregated from all
baseline information to establish a predicted physical therapy visit count and predicted
MDQ change for ALL patients. To do this, the 2 regression models were run
independently—again using only the included cohort. Because patient financial liability
per visit with a large missing value within these data, it was removed from the first
equation predicting visit count to allow for comparison. Coefficients derived from these 2
regression models were then applied to the excluded patients, when possible, to calculate
“Index” values for excluded patients. Independent samples t-tests were used to compare
values of predicted visit count and MDQ change between cohorts; 95% confidence
intervals were also reported to provide clinical context.
Conclusion
These investigations sought to bolster the available body of physical therapy
comparative-effectiveness literature related to patients LBP. Methodology for Research
Question 1 allowed for a deeper understanding of the influence of patient financial
liability on physical therapy visit count and PRO change for patients with nonoperative
LBP; while methodology for Research Question 2 provided evidence for the
generalizability of results derived from the primary investigation. Collectively, methods
for Research Questions 1 and 2 provided a framework for which investigators can better
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understand the relationship between patient characteristics, insurance attributes, clinical
and financial outcomes, and guideline adherent care in patients with nonoperative LBP.

Table 2.1: Variable Consideration by Instrumental Regression Stage
for Research Question 1
Sociodemographic:
Sex
Age
BMI
ZIP Median Income
Disability:
Patient-Reported Comorbid
Health History
Veteran’s RAND 12-Item
Health Survey (VR-12)
Initial MDQ
Instrumental Variables:
Insurance-Level Patient
Financial Liability Per Visit
First Stage Regression Outcome:
Predicted Visit Count

First Stage

Second Stage

X

X

X

X

X
X
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Chapter 3
Instrumental Variable Regression Analysis
Introduction
Low back pain (LBP) is the most common orthopedic complaint in the United
States (U.S.) with an estimated lifetime prevalence of 80%.1 Evidence-based guideline
care recommendations were introduced to reduce costly and unwarranted variation in the
evaluation and management of patients seeking medical care for LBP.2,3 Many of these
care recommendations are routinely applied in outpatient physical therapy settings.
However, there are mixed results when examining health outcomes following physical
therapy interventions.5-15 Variable physical therapist performance and heterogeneity of
treatment effect related to patients’ attitudes, beliefs, willingness to pay and/or
participate, and predisposition to respond to care likely contribute to these findings.16-19
Another factor thought to contribute to variable clinical outcomes is physical
therapy visit count. While sometimes predicated on insurance approval or caps, visit
count is often influenced by the patient’s ability to pay for additional treatment.82 Recent
literature and polling provides evidence that healthcare utilization is adversely affected
by health insurance plans that pass along greater financial responsibility to the patient;
however, there is no evidence that suggests additional physical therapy utilization will
grant patients greater improvement in function (i.e., greater PRO change).82-84 The
purpose of this study was to utilize instrumental variable (IV) regression to exploit
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natural variation in a physical therapy clinical outcomes database to test this
relationship.65-67
IV regression uses a two-stage least squares (2SLS) approach in which the first
stage regresses all explanatory variables (i.e., baseline demographic and outcome
information) and candidate IV(s) (i.e., insurance-level patient financial liability per visit)
to estimate treatment choice (i.e., physical therapy visit count), and the second stage
simultaneously regresses those same baseline explanatory variables (i.e., demographic
and outcome information) AND the first stage outcome (i.e., predicted visit count) to
estimate the terminal health outcome (i.e., PRO change).66,67,85 Results are then
generalizable to a “marginal” subset of patients whose treatment choice (i.e., number of
physical therapy visits attended) is influenced by the instrument(s) (i.e., patient financial
liability per visit).66 IV regression assumes that the IV influences treatment choice but
has no impact on the outcome of treatment.67,68 Harris and Remler69 highlighted 4
conditions a variable must meet for consideration as a valid instrument. The candidate
IV(s) must: 1) influence probability of treatment, 2) not independently effect change in
the outcome of interest, 3) not be influenced by health status or health outcomes
(exogeneity), and 4) only influence the probability of treatment in one direction
(monotonicity). Patient financial liability per visit averaged across a health insurance plan
was proposed as the IV for this investigation. It was thought to influence the number of
visits attended; however, there was no direct theorized influence of insurance plan-level
patient financial liability per visit on PRO change—aside from its effect via visit count.
Finally, because it was aggregated to the insurance level mean, the IV was exogenous to
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any 1 patient. Figure 1 details the representative theoretical model regarding the
hypothesized effect of patient financial liability per visit on physical therapy visits.
The PRO selected for this study was the Modified Low Back Pain Disability
Questionnaire (MDQ), a modification of the Oswestry Disability Index (ODI) and the
most commonly used PRO among physical therapists for patients with LBP.22,32,36 We
hypothesized that patient financial liability per visit would be a strong instrument that
would differentiate utilization among marginal patients whose visits were influenced by
financial concerns. Further, we hypothesized that the additional visits attended by these
marginal patients would result in additional meaningful change in the MDQ.
Methods
Data Sources and Patient Identification:
Patients with LBP that sought physical therapy care between January 2017 and
December 2018 were identified from the ATI Patient Outcomes Registry. This registry,
which is registered with ClinicalTrials.gov (NCT02285868) and the US Department of
Health and Human Services Agency for Healthcare Research and Quality in the Registry
of Patient Registries (2608), was also queried for baseline patient information and patient
reported outcomes (PROs) throughout the physical therapy episode of care. Separate data
sets also provided granular scheduling data and final adjudicated financial claims for
identified patients. This study followed the REporting of studies Conducted using
Observational Routinely collected Data (RECORD) initiative and was reviewed and
approved by The University of South Carolina Institutional Review Board
(Pro00090115).77
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Inclusion & Exclusion Criteria (Figure 3.2):
An initial query for all nonoperative patients 18-64 years of age with LBP that
completed the MDQ and Veterans RAND 12-Item Health Survey (VR-12) at an initial
physical therapy evaluation with commercial insurance yielded 65,924 unique patient
episodes.43 Only patients with a follow-up MDQ, complete baseline demographic
information described below, scheduling information, and final adjudicated financial
claims were included, yielding 25,382 unique patient episodes. Race was missing in
97.6% of patient episodes and excluded for consideration as a factor. Body mass index
(BMI) was available for 81.5% of patient episodes and included in models below as
quintiles. A 6th classification assigned to those with missing BMI to avoid a further
decline in sample size. Table 3.1 describes the available sample, the cohort of included
patients, and patients split into quintiles by the instrumental variable (i.e., insurance planlevel patient financial liability per visit). Chapter 4 further explores the comparison of
included and excluded patients for an expanded look at generalizability of the below
clinical findings.
Statistical Framework & Computing:
Two-stage least squares (2SLS) instrumental variable (IV) regression with Robust
Standard Errors (RSEs) was utilized. Detailed above, 2SLS IV regression allows for
causal inference by exploiting natural variation in the data. Analyses and plots were
completed in R using the ‘Applied Econometrics with R’ (AER) and ‘ggplot2’ packages,
respectively.76,86,87
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Instrument Development:
To ensure the proposed IV met the exogeneity requirement—and due to variety of
health insurance plan structures vary (i.e., copayment or deductible and coinsurance)—
preliminary work was required to develop a suitable instrument. Patients were grouped
by insurance plan and a mean value of patient financial responsibility per visit between
initial and final MDQ was calculated and assigned to each patient within the plan. For
this measure to be exogenous to any 1 patient, a minimum of 20 patients per plan was
required. This requirement further reduced the final analytical sample to 21,541 unique
patient episodes.
Stage 1: Modeling Visit Count
Stage 1 included patient financial liability per visit as the IV and modeled the
number of physical therapy visits attended by each patient. Additional explanatory
variables theorized to influence physical therapy visits included patient sex, payer (i.e.,
Medicare or Commercial), quintile of age at initial evaluation, quintile of BMI at initial
evaluation (with a 6th category for the 18.5% with missing BMI), stage of physical
therapy services, ZIP-level median income where the patient resides, initial MDQ, initial
mental (MCS) and physical (PCS) component scores of the Veteran’s RAND 12-Item
Health Survey (VR-12), and individual comorbidities identified from a patient-reported
medical history form.
Stage 2: Modeling MDQ Change
The Stage 1 predicted physical therapy visit count was included in the Stage 2
regression predicting MDQ change. Explanatory variables used in Stage 1 have been
demonstrated to influence PRO change and were also included in Stage 2.16,17,27,28
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Because these variables were used in Stage 1 to predict visit count, only the portion of
these independent variables that predict change in MDQ independent of their indirect
effect on change in MDQ through predicted number of physical therapy visits attended
was accounted for in this stage.
Results
Inclusion and exclusion criteria were met for 21,541 unique patient episodes
(Table 3.1). Insurance-level mean patient financial liability was $42 per visit (range $8,
$142). The first-stage F-test indicated borderline strength of the IV (F = 9.8); however,
the effect of the IV trended opposite to theoretical model by quintile of the IV (Table
3.2). Visit count predicted in the first stage was a statistically significant positive
predictor of MDQ change (P = 0.02) with a 0.8 point increase in MDQ change per
additional “marginal” visit.
Table 3.1 describes patients by quintile of patient financial liability per visit.
Baseline values by quintile were relatively uniform aside from ZIP-level median income,
which was observed to be lower in quintile 3. There were no other clinically important
differences identified between quintiles. Tables 3.2 and 3.3 highlight first and second
stage regression coefficients, respectively, with robust standard errors and 95% CIs
provided. Select comorbid history, initial MDQ, ZIP-level median income, chronic status,
patient financial liability exceeding $45 per visit, age exceeding 52.5 years, and initial
VR-12 PCS were the strongest predictors of physical therapy visit count; while select
comorbid history, sex, initial MDQ, initial VR-12 MCS and PCS, chronic status, body
mass index (BMI) exceeding 33.1, and predicted visits were the strongest predictors of
change in MDQ in the second stage.
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Discussion
Summary of Findings:
Patient financial liability did not function in a manner consistent with a priori
theory. The IV demonstrated borderline strength per the first stage F-test; however, as
patient financial liability per visit increased, visits trended upward. This is a major
limitation to the study as the underlying theoretical framework was proven false; further
detailed below. Consistent with prior investigations, initial PRO and VR-12, chronic
status, status of services, sex, and select comorbidities were significant predictors of PRO
change.16,17,27,28 Interestingly, while ZIP-level median income was previously identified
as a significant predictor of MDQ change, it was not a significant predictor in the 2nd
stage regression equation. Instead, it significantly influenced physical therapy visit count,
and previously identified effect on MDQ change may have been indirect through its
effect on visit count.
Instrumental Variable Utility:
A retrospective analysis of insurance plan-level patient financial liability per visit
as an instrument identifies significant weaknesses in its use.69 While patient financial
liability per physical therapy visit demonstrated borderline strength as an instrument, the
generally monotonic relationship the IV had with visit count trended away from the
theorized direction. As a result, no significant inferences can be derived from the data asis. It is believed this was a function of missing individual-level socioeconomic status and
plan structure. Recent evidence supports the idea that these unmeasured confounders—
specifically high income beneficiaries selecting high deductible, health savings account-
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style policies and trending toward increased healthcare use despite greater patient
financial liability—likely contribute to these results.47,70
Interpretation of Findings:
While a natural experiment was observed in Table 3.1, findings were likely
influenced more by individual socioeconomic status and insurance plan structure than
previously hypothesized. A telling finding in support of this hypothesis is the dip in visit
count in the 3rd quintile—consistent with the dip in ZIP-level median income. An ideal
methodological framework would allow for control of area SES (ZIP-level), individuallevel SES, plan structure (i.e., copayment-based, low deductible coinsurance-based, and
high deductible coinsurance-based), and the interaction of individual-level SES and plan
structure. While it is unlikely that individual-level SES will ever become available in a
real-world electronic health record-based study, further investigation including plan
structure is warranted.
Aside from concerns regarding the IV, the coefficient for visit count was 0.8
(95% CI 0.1,1.5). Since this applies only to “marginal” visits, this additional change is
not one that approaches clinical significance. With values of MCID estimated at 6 and 10,
these results indicate that a minimum of 6-7 additional visits would be required before
clinical change would occur.
Limitations:
Secondarily obtained observational data are not obtained for research purposes,
and therefore are subject to unmeasured confounding. A prior study highlighted that only
19% of variability in change in MDQ is associated with measured baseline patient
characteristics leaving the vast majority of variance unexplained.16 Secondly, the IV did
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not function as hypothesized. As described above, issues with the IV likely arose due to
lacking information related to individual SES and health insurance plan structure. Due to
this limitation, more detailed baseline information is required before confidence in the
results of these analyses is established. Finally, Chapter 4 explores the generalizability of
physical therapy patient reported outcomes research as a result of those lost to follow-up.
In addition to the 42.6% of patients that failed to complete a follow-up MDQ, an
additional 14.8% of the total population had scheduling, ZIP-level median income, or
financial liability information missing—or were enrolled in a health insurance plan with
fewer than 20 enrollees in our data sample. This leaves a final sample of 21,541 (32.7%)
from which inferences were made. While this remains a large sample—there were more
patients excluded (n = 65,924 [67.3%]) than included and this limits the generalizability
of our results.
Conclusions
Patient financial liability per visit influenced visit count in a marginal population
of patients—but the associated difference was counter to a priori hypotheses. Additional
data is warranted to test the theory that plan structure plans a large role in the proposed
interrelationship between patient financial liability, visit count, and PRO change. While
an ideal model would include individual-level SES, this is unmeasurable in a secondarily
obtained electronic health record-based investigation.
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Table 3.1: Description of Total Patients, Included Sample, and Quintiles of Patient Financial Liability Per Visit

Count
Age
Sex, Male
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BMIǂ
Patient
Financial
Liability Per
Visitǂ
Initial MDQ
MDQ Changeǂ
Initial
VR-12 MCS
Initial
VR-12 PCS
Comorbidity
Count
Visits
ZIP-Level
Median Income

Total
Patient
Population
65,924
46.4 ± 12.7
28,054
(42.6%)
29.4 ± 7.0

Included
Patient
Sample
21,541
46.2 ± 12.9
9,009
(41.8%)
29.2 ± 6.9

Quintile 1

Quintile 2

Quintile 3

Quintile 4

Quintile 5

4,752
47.0 ± 13.1
3,964
(37.4%)
29.2 ± 7.0

3,840
45.7 ± 12.9
3,982
(37.6%)
28.8 ± 6.8

4,459
46.3 ± 13.1
4,199
(39.6%)
29.4 ± 6.9

4,337
46.6 ± 12.5
4,449
(42.0%)
29.4 ± 6.9

4,153
45.1 ± 12.7
4,531
(42.8%)
28.9 ± 6.8

$40.67 ±
$17.56

$42.70 ±
$22.34

$25.30 ±
$5.79

$40.70 ±
$2.36

$47.30 ±
$2.22

$67.00 ±
$1.98

$56.43 ±
$23.35

32.2 ± 17.7
10.6 ± 15.2

31.3 ± 15.4
11.3 ± 15.4

32.3 ± 17.8
10.3 ± 15.4

30.7 ± 17.1
11.6 ± 15.5

31.5 ± 16.6
11.3 ± 15.3

31.3 ± 16.7
11.7 ± 15.2

30.7 ± 17.0
11.6 ± 15.6

39.2 ± 6.9

39.3 ± 6.9

39.3 ± 6.9

39.7 ± 6.6

39.3 ± 6.7

39.3 ± 6.8

39.8 ± 6.6

37.6 ± 6.3

37.6 ± 6.2

37.3 ± 6.2

37.7 ± 6.3

37.5 ± 6.1

37.6 ± 6.1

37.8 ± 6.3

2.3 ± 2.5

2.2 ± 2.3

2.4 ± 2.5

2.0 ± 2.1

2.3 ± 2.3

2.2 ± 2.2

2.0 ± 2.1

9.1 ± 7.0¥
66,477 ±
24,571

13.1 ± 6.9
13.1 ± 7.0
13.0 ± 6.8
12.1 ± 6.0
13.6 ± 7.3
13.9 ± 7.1
68,846 ±
69,274 ±
72,323 ±
62,689 ±
67,319 ±
73,346 ±
24,885
28,172
26,581
20,823
22,497
24,133
Values Represent Mean ± Standard Deviation or Count (Column %)
ǂ
As Available; * Quintile Differences p < 0.05; ¥ Expected Variation Relative to Other Columns Due to Incomplete Episodes of Care

Table 3.2: First Stage Instrumental Variable Regression Coefficients Predicting Physical
Therapy Visit Count

Intercept
Initial MDQ
Initial VR12 – MCS
Initial VR12 – PCS
BMI: Quintile 2
BMI: Quintile 3
BMI: Quintile 4
BMI: Quintile 5
BMI: Missing
Age: Quintile 2
Age: Quintile 3
Age: Quintile 4
Age: Quintile 5
Condition ≥ 90 Days
Sex (Male)
History:
Bowel & Bladder
Problems
History:
High Blood Pressure
History:
Diabetes (Any)
History:
Allergy (Non-Latex)
History:
Smoking
History:
Night Sweats &/or Pain
History:
Cancer
History:
Metal Implants
History:
Groin Numbness
History:
Fracture
History:
Arthritis (Any)
History:
Stroke
History:
Allergy – Latex
History:
Ringing in Ears

Coefficient

Coefficient
95% CI

9.1
0.04
-0.01
-0.03
0.0
-0.1
-0.1
0.3
-0.1
-0.4
-0.5
-0.6
-0.6
0.5
-0.3

-3.2,21.5
0.03,0.04
-0.02,0.01
-0.04,-0.01
-0.3,0.3
-0.4,0.2
-0.4,0.2
0.0,0.6
-0.4,0.2
-0.7,-0.1
-0.8,-0.2
-0.9,-0.3
-0.9,-0.3
0.3,0.8
-0.5,-0.1

Robust
Standard
Error
6.2
0.00
0.01
0.01
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1

0.2

-0.1,0.6

0.1

t-statistic

p-value

1.476
13.658
-1.129
-3.722
0.057
-0.720
-0.481
2.106
-0.559
-3.046
-3.415
-4.193
-3.682
4.161
-2.959

0.140
<0.001***
0.259
<0.001***
0.955
0.471
0.631
0.035*
0.576
0.002**
0.001**
<0.001***
<0.001***
<0.001***
0.003**

0.2

1.511

0.131

-0.1,0.3

0.1

0.693

0.488

0.2

-0.1,0.5

0.2

1.199

0.230

0.5

0.3,0.7

0.1

4.869

<0.001***

-0.5

-0.7,-0.2

0.1

-3.589

<0.001***

0.2

-0.1,0.4

0.1

1.229

0.219

0.2

-0.2,0.6

0.2

0.944

0.345

0.4

0.1,0.8

0.2

2.942

0.003**

-0.1

-0.6,0.4

0.3

-0.385

0.700

0.3

-0.1,0.6

0.2

1.355

0.175

0.0

-0.2,0.2

0.1

0.217

0.828

0.0

-0.8,0.8

0.4

0.038

0.970

0.0

-0.4,0.5

0.2

0.182

0.855

0.4

0.1,0.6

0.1

2.577

0.010*
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History:
-0.3
-1.0,0.3
0.3
-1.013
0.311
Infection
History:
-0.3
-0.7,0.1
0.2
-1.532
0.126
Heart Condition
History:
Blood Clot /
0.8
0.3,1.4
0.3
2.901
0.004**
Deep Vein Thrombosis
History:
-0.6
-1.1,0
0.3
-2.180
0.029*
Kidney Condition
History:
0.4
-0.1,0.9
0.2
1.479
0.139
Sexual Dysfunction
History:
0.4
-0.3,1.2
0.4
1.128
0.259
Seizures
History:
-0.8
-1.5,-0.1
0.4
-2.248
0.025*
Pregnant
History:
0.0
-0.5,0.6
0.3
0.149
0.882
Fever or Nausea
History:
-0.8
-1.5,-0.1
0.3
-2.337
0.019*
Double Vision
History:
0.1
-0.8,1
0.5
0.204
0.838
Unexplained Weight Loss
History:
0.5
-0.7,1.7
0.6
0.886
0.375
Pacemaker
History:
Breathing Difficulties /
0.2
-0.1,0.4
0.1
1.335
0.182
Asthma
History:
0.3
-0.3,0.9
0.3
1.024
0.306
Difficulty Swallowing
History:
-0.5
-0.9,-0.1
0.2
-2.324
0.020*
Osteoporosis
History:
0.5
0.1,0.8
0.2
2.681
0.007**
Psychological Condition
History:
0.3
-0.2,0.7
0.2
1.113
0.266
Chest Pain
ZIP-Level Median Income
0.1
0.1,0.1
0.0
5.711
<0.001***
(per $10,000)
Financial Liability Per
0.2
-0.1,0.5
0.1
1.655
0.098
Visit: Quintile 2
Financial Liability Per
-0.1
-0.5,0.2
0.2
-0.797
0.425
Visit: Quintile 3
Financial Liability Per
0.7
0.4,1.0
0.2
4.240
<0.001***
Visit: Quintile 4
Financial Liability Per
0.6
0.3,1.0
0.2
3.514
<0.001***
Visit: Quintile 5
Coefficients, Confidence Intervals (CIs), and Errors Rounded to 1 Decimal Except as Noted
*p<0.05 **p<0.01 ***p<0.001
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Table 3.3: Second Stage Instrumental Variable Regression Coefficients Predicting MDQ
Change

Intercept
Initial MDQ
Initial VR12 – MCS
Initial VR12 – PCS
BMI: Quintile 2
BMI: Quintile 3
BMI: Quintile 4
BMI: Quintile 5
BMI: Missing
Age: Quintile 2
Age: Quintile 3
Age: Quintile 4
Age: Quintile 5
Condition ≥ 90 Days
Sex (Male)
History:
Bowel & Bladder
Problems
History:
High Blood Pressure
History:
Diabetes (Any)
History:
Allergy (Non-Latex)
History:
Smoking
History:
Night Sweats &/or Pain
History:
Cancer
History:
Metal Implants
History:
Groin Numbness
History:
Fracture
History:
Arthritis (Any)
History:
Stroke
History:
Allergy – Latex
History:
Ringing in Ears

Coefficient

Coefficient
95% CI

-22.5
0.49
0.16
0.15
0.1
0.1
0.4
-1.7
-0.6
-0.5
-1.1
-1.3
-1.5
-2.1
1.3

-29.9,-15.2
0.46,0.52
0.13,0.20
0.11,0.19
-0.6,0.7
-0.6,0.8
-0.3,1.1
-2.4,-0.9
-1.3,-0.0
-1.2,0.1
-1.8,-0.4
-2.0,-0.5
-2.2,-0.7
-2.8,-1.5
0.9,1.8

Robust
Standard
Error
3.7
0.02
0.02
0.02
0.3
0.3
0.3
0.4
0.3
0.3
0.4
0.4
0.4
0.3
0.2

-2.1

-2.8,-1.3

-0.5

t-statistic

p-value

-6.113
31.285
9.220
7.024
0.181
0.326
1.146
-4.399
-2.006
-1.654
-3.270
-3.347
-3.727
-6.618
5.784

<0.001***
<0.001***
<0.001***
<0.001***
0.856
0.745
0.252
<0.001***
0.045*
0.098
<0.001***
0.001**
<0.001***
<0.001***
<0.001***

0.4

-5.461

<0.001***

-1.0,0.0

0.3

-1.918

0.055

-1.3

-2.0,-0.5

0.4

-3.308

0.001**

-0.2

-0.8,0.4

0.3

-0.517

0.605

-1.3

-2.0,-0.6

0.4

-3.617

<0.001***

-2.9

-3.5,-2.3

0.3

-9.712

<0.001***

0.5

-0.5,1.4

0.5

1.032

0.302

-2.7

-3.5,-1.9

0.4

-6.788

<0.001***

-2.4

-3.6,-1.2

0.6

-4.021

<0.001***

-0.8

-1.7,0.0

0.4

-1.934

0.053

-2.8

-3.3,-2.3

0.2

-11.278

<0.001***

-2.1

-4.1,-0.0

1.0

-1.978

0.048*

-1.1

-2.2,-0.1

0.5

-2.125

0.034*

-0.8

-1.5,-0.2

0.3

-2.441

0.015*
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History:
0.0
-1.5,1.5
0.8
0.033
0.973
Infection
History:
-0.1
-1.0,0.8
0.4
-0.280
0.780
Heart Condition
History:
Blood Clot /
0.4
-1.1,1.8
0.7
0.523
0.601
Deep Vein Thrombosis
History:
0.1
-1.1,1.4
0.6
0.232
0.817
Kidney Condition
History:
-2.4
-3.6,-1.2
0.6
-3.993
<0.001***
Sexual Dysfunction
History:
-3.6
-5.6,-1.7
1.0
-3.754
<0.001***
Seizures
History:
-4.7
-6.8,-2.7
1.0
-4.712
<0.001***
Pregnant
History:
-0.3
-1.6,1.0
0.6
-0.430
0.667
Fever or Nausea
History:
-0.8
-2.6,1.0
0.9
-0.868
0.385
Double Vision
History:
Breathing Difficulties /
-0.9
-4.3,-0.0
1.1
-1.967
0.049*
Asthma
History:
-2.2
-3.3,1.6
1.2
-0.732
0.464
Unexplained Weight Loss
History:
-0.9
-1.5,-0.3
0.3
-2.817
0.005**
Pacemaker
History:
-0.9
-4.3,-1.4
0.7
-3.979
<0.001***
Difficulty Swallowing
History:
-2.9
-1.0,1.2
0.5
0.189
0.850
Osteoporosis
History:
0.1
-3.0,-1.2
0.5
-4.584
<0.001***
Psychological Condition
History:
-2.1
-2.7,-0.5
0.6
-2.799
0.005**
Chest Pain
ZIP-Level Median Income
.00
-0.12,0.12
0.06
0.122
0.903
(per $10,000)
Predicted Physical
0.8
0.1,1.5
0.4
2.329
0.020*
Therapy Visit Count
Coefficients, Confidence Intervals (CIs), and Errors Rounded to 1 Decimal Except as Noted
*p<0.05 **p<0.01 ***p<0.001
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Figure 3.1: Representative Theoretical Model (Not Actual Data)
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Figure 3.2: Study Inclusion/Exclusion Flow Diagram
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Chapter 4
Generalizability of Comparative Effectiveness Research with Missing Data
Introduction
Research endeavors often take place in a ‘real world’ environment to improve
available sample and maximize generalizability.16,17,27-29,52,72,73 The United States
Department of Health and Human Services defines comparative effectiveness research
(CER) as research that compares “the benefits and harms of different interventions and
strategies to prevent, diagnose, treat and monitor health conditions in “real world”
settings.”74 It aims to clarify the effectiveness of established health interventions.75
Donabedian61 called health outcomes the “ultimate validators of the effectiveness and
quality of medical care”. Health outcomes, including PROs, are often missing in these
‘real world’ research designs, leading investigators to explain away the missingness and
its effect on validity and generalizability.62-64 While problematic in prospective cohortbased studies, the problem of missing PROs is magnified when examining secondarily
obtained observational data from electronic health records (EHRs) and other healthcare
databases. Patient reported outcomes derived from EHRs are often used in orthopaedic
physical therapy research to test the effectiveness of interventions and
therapists.9,16,17,24,25,27-30,33,34 There is wide variation in collection of follow-up PROs
across the rehabilitation industry, and little is understood regarding the appropriate
handling of these missing outcomes and the impact of missingness on generalizability of
results.16,17,25,27,29,30
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Because “real world” health information—and pragmatic research approaches—
often lack data, it would be beneficial to better understand how generalizable the
inferences made on the “complete cases” is to the broader, less complete patient
population. As a representative sample, the initial cohort of patients with LBP identified
in Chapter 3 required the inclusion of several distinct data sets, limiting the included
sample to 32.7% of the available patients with low back pain (LBP). The purpose of this
study was to thoroughly vet baseline patient information and patient reported outcomes
(PROs) to establish a level of confidence of generalizability of the results to the broader
physical therapy patient population. While baseline patient information accounts for less
than 40% of the variability in change of PROs, if these data are comparable between
included and excluded cohorts, it would improve confidence in the generalizability of our
results and inferences.16,17,30 We hypothesized that these baseline values would be
comparable, and the inferences made would generalize well to the broader patient
population—understanding that limitations remain, given the unexplained variability.
Methods
Data Sources:
Commercially insured, nonoperative patients 18 to 64 years of age with LBP that
sought physical therapy care between January 2017 and December 2018 were identified
from the ATI Patient Outcomes Registry. This registry, which is registered with
ClinicalTrials.gov (NCT02285868) and the US Department of Health and Human
Services Agency for Healthcare Research and Quality in the Registry of Patient
Registries (2608), was also queried for baseline patient information and patient reported
outcomes (PROs) throughout the physical therapy episode of care. Separate data sets also
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provided scheduling information and final adjudicated financial claims data for identified
patients. This study followed the REporting of studies Conducted using Observational
Routinely collected Data (RECORD) initiative and was reviewed and approved by The
University of South Carolina Institutional Review Board (Pro00090115).77
Inclusion & Exclusion Criteria:
Chapter 3 (Figure 3.2) details the process from which the final included
(n=21,541) and excluded (n=44,383) samples were derived.
Comparison of Baseline Patient Characteristics:
Independent samples t-tests compared baseline numeric variables (i.e., age, body
mass index [BMI], Modified Low Back Pain Disability Questionnaire [MDQ], Mental
[MCS] and Physical [PCS] Component Scores of the Veteran’s RAND 12-Item Health
Survey [VR-12], count of comorbid conditions, insurance plan-level patient financial
liability per visit, and census-derived ZIP-level median income) between the included and
excluded cohorts with 95% confidence intervals (CIs) reported; while chi-square analyses
tested for differences baseline categorical variables (i.e., sex and condition present ≥ 90
days at initial evaluation).
Comparison of Predicted ‘Index’ Values:
The investigation in Chapter 3 involved a 2-stage least squares (2SLS)
instrumental variable (IV) regression approach using all baseline patient factors described
above (i.e., age, BMI, initial MDQ, initial VR-12 mental and physical component scores,
individual comorbid conditions, chronic status, ZIP-level median income, and the IV—
insurance-level patient financial liability per visit) to predict visit count in the first
stage—then all baseline patient factors and predicted visit count (excluding insurance-
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level patient financial liability per visit) to predict PRO change in the second stage. The
first stage model—excluding insurance-level patient financial liability per visit—was
then run separately using the included cohort of patients. Coefficients derived from this
model were then applied to excluded patients for whom all baseline information was
available for calculation of a single comparator “index” value for predicted visits.
Similarly, the second stage model—excluding predicted visit count—was run separately
using the included cohort of patients. Coefficients from this model were also derived and
applied to excluded patients with all available baseline information for calculation of a
single comparator “index” value for predicted MDQ change. Independent samples t-tests
were used to compare values of predicted visit count and change in MDQ between
cohorts, and 95% confidence intervals were reported for additional clinical context.
Statistical Computing:
Analyses and plots were completed in R, with plots requiring the ‘ggplot2’
package.76,87
Results
Baseline and Clinical Course of Care Comparisons
Baseline comparisons were made between the 21,541 unique included patient
episodes and 44,383 unique excluded patient episodes, as available. Table 4.1 describes
patients in each cohort, including the number of missing values by variable in the
excluded group. Table 4.1 also compares these values for statistical significance. Of the
observed baseline clinical factors, age, sex, initial MDQ, comorbidity count, and
insurance-level patient financial responsibility per visit were statistically different

45

between cohorts (P<0.001). Of the clinical course of care factors, attended visits and
MDQ change were also statistically different between cohorts (P<0.001).
Index Comparisons
Of the 44,383 excluded patient episodes, the vast majority (n = 41,354) had
required baseline information described above as required for regression modeling
predicting “index” values of predicted physical therapy visit count and MDQ change.
Tables 4.2 and 4.3 detail coefficients with robust standard errors and statistical
significance derived for predicted visit count and MDQ, respectively. The “index” value
for predicted visit count was statistically different (P<0.001) between all included
patients (13.1 ± 1.7) and all excluded patients (12.9 ± 1.8). The “index” value for
predicted MDQ change was also statistically different (P<0.001) between all included
patients (11.3 ± 8.3) and all excluded patients (10.9 ± 8.6). Histograms represented in
Figures 4.1 and 4.2 compare predicted visit count and MDQ change between cohorts,
respectively.
Discussion
The above results were further analyzed to determine if differences reached the
level of clinical importance. While statistical differences were identified for initial MDQ
(1.4 points on a 100 point scale), insurance-level patient financial responsibility per visit
($2.80 per visit), VR-12 MCS (0.5), comorbidity count (historical difference of 0.2
comorbidities), and sex (1.1% difference), these differences do not appear to represent
clinically important amounts.22,36 Differences in visits attended between the included and
excluded cohorts (6.0 visits) were statistically different—and appear to also represent
clinical importance. While this difference appears large, it is a logical disparity—as
follow-up PRO completion is often a function of visit count and time—and a primary
46

reason for undertaking this in-depth analysis. Possibly related to the lower visit count—
and discussed extensively in Chapter 3—is the significantly lower ZIP-level median
income in the excluded patients ($3,520 lower annually). It is possible, but impossible to
verify, that many of these patients were unable to complete care as recommended due to
financial barriers to care. Finally, MDQ change (1.9 points on a 100 point scale) was
statistically different between cohorts; however, minimal clinically important differences
of 6 and 10 have been published for the Oswestry Disability Index and its modified
versions, making the observed difference clinically unimportant.22,36
The ‘index’ measures of predicted visit count and change in MDQ failed to
identify clinically important differences. While baseline information explains only 6.1%
of variability in predicted visit change and 28.5% of variability in change in MDQ, this
study confirms that independent baseline values and the aggregated ‘index’ scores for
predicted visit count and change in MDQ are largely the same between cohorts of
included and excluded patients.
Management of missing data is of broad interest in outcomes research.
Investigators are often forced to explain away the importance of missing data (as we have
here) and/or use complex methods to account for the absence of importance information.
Mean imputation and inverse probability weighting have been used in orthopaedic
physical therapy outcomes research; however, those methods simply offer educated
guesses at the outcome(s) or differently weight the included patients relative to their
likelihood of outcome completion, respectively, and limitations persist in their
inference.17,88,89 As more data is available, if researchers consistently find congruence
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between included and excluded patients, our confidence in generalizability will continue
to improve and we can become less reliant on these complex statistics.
Conclusions
Few clinically important differences in baseline patient and clinical course of care
information was identified between included and excluded cohorts, as noted above.
While results of this study provide evidence of generalizability of results of findings in
Chapter 3—and broadly to other pragmatic physical therapy outcomes studies—there
remains some caution when considering generalizability of results. Large amounts of
unexplained variance in models predicting visit count and change in MDQ remain.
Factors known or theorized to influence these outcomes such as patient financial liability
per visit, individual-level socioeconomic status, individual health insurance plan
structure, provider, clinic, and race could not be accounted for in the above regression
models due to missing or unknown information (i.e., race and patient financial liability
across the vast majority of the excluded cohort) or incongruence with the methods in
Chapter 3 (i.e., provider and clinic) as they resulted in singularity of the two-stage least
squares regression model utilized.16,17,25,27-30 Even so, using all available information, we
were unable to identify differences between the included and excluded cohorts that would
significantly threaten the validity or generalizability of observed results.
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Table 4.1: Comparison of Included and Excluded Patients
Statistical
Difference

Included

Excluded

Total Count
Visits
Initial MDQ¹

Patient
Missing
Makeup
n = 21,541
13.1 ± 7.1
0
31.3 ± 17.1
0

MDQ¹ Change

11.3 ± 15.4

0

Patient
Missing
Makeup
n = 44,383
7.1 ± 6.1
0
32.7 ± 18.0
0
31,313
9.4 ± 14.9
(70.6%)

42.3 ± 17.5

0

39.5 ± 17.5

13,327
(30.0%)

P < 0.001

68,846 ±
24,885

0

65,326 ±
24,334

91 (0.2%)

P < 0.001*

Patient
Financial
Responsibility
Per Visit
ZIP-Level
Median
Income

46.2 ± 12.9

4,022
(18.7%)
0

46.4 ± 12.6

9,068
(20.4%)
0

3.3 ± 2.8

0

3.0 ± 2.8

0

BMI²

29.2 ± 6.9

Age
Comorbidity
Count
VR12³ MCS⁴
VR12³ PCS⁵

29.5 ± 7.0

P < 0.001*
P < 0 .001
P < 0.001

P < 0.001
P = 0.012
P < 0.001

39.5 ± 6.7
0
39.1 ± 7.0
2,943 (6.6%)
P < 0.001
37.6 ± 6.3
0
37.6 ± 6.3
2,940 (6.6%)
P = 0.703
21,125
29,907
Sex: Male
0
0
P = 0.008
(39.9%)
(41.9%)
Values Represented as Mean ± Standard Deviation or Count (%)
¹ Modified Low Back Pain Disability Questionnaire,
² Body Mass Index, ³ Veterans RAND 12-Item Health Survey,
⁴ Mental Component Score, ⁵ Physical Component Score, *Potential Clinical Difference
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Table 4.2: Regression Coefficients Predicting Physical Therapy Visit Count: Derived
from Included Patient Cohort (Note: Coefficients for State of Physical Therapy
Services Excluded from Table)

70
0.05
0.00
-0.03
0.0
-0.2
-0.2
0.3
-0.1
-0.3
-0.4
-0.6
-0.7
0.4
-0.3

Robust
Standard
Error
6.7
0.00
0.01
0.01
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.1

0.3

0.2

1.752

0.080

0.1

0.1

0.968

0.333

0.2

0.2

1.235

0.217

0.5

0.1

4.629

<0.001***

-0.5

0.1

-3.499

<0.001***

0.2

0.1

1.546

0.122

0.2

0.2

0.732

0.464

0.6

0.2

3.386

0.001**

-0.3

0.3

-0.940

0.347

0.7

0.2

3.336

0.001**

0.1

0.1

0.872

0.383

-0.1

0.4

-0.288

0.773

0.0

0.2

-0.128

0.898

0.3

0.2

2.035

0.042*

-0.3

0.3

-0.946

0.344

Coefficient
Intercept
Initial MDQ
Initial VR12 – MCS
Initial VR12 – PCS
BMI: Quintile 2
BMI: Quintile 3
BMI: Quintile 4
BMI: Quintile 5
BMI: Missing
Age: Quintile 2
Age: Quintile 3
Age: Quintile 4
Age: Quintile 5
Condition ≥ 90 Days
Sex (Male)
History:
Bowel & Bladder Problems
History:
High Blood Pressure
History:
Diabetes (Any)
History:
Allergy (Non-Latex)
History:
Smoking
History:
Night Sweats &/or Pain
History:
Cancer
History:
Metal Implants
History:
Groin Numbness
History:
Fracture
History:
Arthritis (Any)
History:
Stroke
History:
Allergy – Latex
History:
Ringing in Ears
History:
Infection

50

t-statistic

p-value

1.051
15.661
-0.562
-3.063
-0.283
-0.936
-1.010
1.810
-0.471
-1.962
-2.734
-4.011
-4.056
2.934
-3.367

0.293
<0.001***
0.574
0.002**
0.777
0.349
0.313
0.07
0.638
0.05
0.006**
<0.001***
<0.001**
0.003**
0.001**

History:
-0.3
0.2
-1.687
0.092
Heart Condition
History:
Blood Clot /
0.9
0.3
2.998
0.003**
Deep Vein Thrombosis
History:
-0.7
0.3
-2.397
0.017*
Kidney Condition
History:
0.5
0.3
2.053
0.040*
Sexual Dysfunction
History:
0.5
0.4
1.335
0.182
Seizures
History:
-0.9
0.4
-2.422
0.015*
Pregnant
History:
0.1
0.3
0.331
0.741
Fever or Nausea
History:
-0.6
0.4
-1.722
0.085
Double Vision
History:
0.6
0.5
1.155
0.248
Unexplained Weight Loss
History:
0.4
0.6
0.639
0.523
Pacemaker
History:
Breathing Difficulties /
0.2
0.1
1.081
0.280
Asthma
History:
0.3
0.3
0.972
0.331
Difficulty Swallowing
History:
-0.6
0.2
-2.680
0.007**
Osteoporosis
History:
0.6
0.2
3.335
0.001**
Psychological Condition
History:
0.2
0.3
0.855
0.392
Chest Pain
ZIP-Level Median Income
0.2
0.0
7.625
<0.001***
(per $10,000)
Adjusted R-squared 0.06, Root Mean Squared Error 6.7
Coefficients & Standard Errors Rounded to 1 Decimal (except as noted)
*p<0.05 **p<0.01 ***p<0.001
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Table 4.3: Regression Coefficients Predicting MDQ Change: Derived from Included
Patient Cohort (Note: Coefficients for State of Physical Therapy Services Excluded
from Table)

-14.6
0.52
0.15
0.12
0.1
0.0
0.3
-1.4
-0.7
-0.9
-1.5
-1.8
-1.9
-1.7
1.1

Robust
Standard
Error
13.1
0.01
0.01
0.02
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.2

-1.9

0.3

-5.528

<0.001***

-0.4

0.2

-1.836

0.066

-1.1

0.3

-3.379

0.001**

0.3

0.2

1.189

0.234

-1.7

0.3

-6.041

<0.001***

-2.8

0.3

-10.697

<0.001***

0.6

0.4

1.521

0.128

-2.3

0.3

-7.114

<0.001***

-2.5

0.5

-4.655

<0.001***

-0.6

0.4

-1.597

0.110

-2.8

0.2

-12.328

<0.001***

-2.1

0.9

-2.405

0.016*

-1.1

0.5

-2.351

0.019*

-0.6

0.3

-1.874

0.061

-0.2

0.7

-0.355

0.723

Coefficient
Intercept
Initial MDQ
Initial VR12 – MCS
Initial VR12 – PCS
BMI: Quintile 2
BMI: Quintile 3
BMI: Quintile 4
BMI: Quintile 5
BMI: Missing
Age: Quintile 2
Age: Quintile 3
Age: Quintile 4
Age: Quintile 5
Condition ≥ 90 Days
Sex (Male)
History:
Bowel & Bladder Problems
History:
High Blood Pressure
History:
Diabetes (Any)
History:
Allergy (Non-Latex)
History:
Smoking
History:
Night Sweats &/or Pain
History:
Cancer
History:
Metal Implants
History:
Groin Numbness
History:
Fracture
History:
Arthritis (Any)
History:
Stroke
History:
Allergy – Latex
History:
Ringing in Ears
History:
Infection
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t-statistic

p-value

-1.115
87.477
10.492
7.631
0.226
0.076
1.025
-4.143
-2.237
-3.093
-5.211
-5.849
-6.038
-6.620
5.588

0.265
<0.001***
<0.001***
<0.001***
0.821
0.939
0.305
<0.001***
0.025*
0.002**
<0.001***
<0.001***
<0.001***
<0.001***
<0.001***

History:
-0.4
0.4
-0.893
0.372
Heart Condition
History:
Blood Clot /
1.1
0.6
1.778
0.075
Deep Vein Thrombosis
History:
-0.4
0.6
-0.639
0.523
Kidney Condition
History:
-2.1
0.5
-4.079
<0.001***
Sexual Dysfunction
History:
-3.3
0.8
-4.113
<0.001***
Seizures
History:
-5.4
0.8
-7.190
<0.001***
Pregnant
History:
-0.2
0.6
-0.435
0.664
Fever or Nausea
History:
-1.4
0.7
-1.992
0.046*
Double Vision
History:
-2.1
1.0
-2.165
0.030*
Unexplained Weight Loss
History:
-0.5
1.3
-0.379
0.705
Pacemaker
History:
Breathing Difficulties /
-0.7
0.3
-2.608
0.009**
Asthma
History:
-2.6
0.6
-4.028
<0.001***
Difficulty Swallowing
History:
-0.3
0.5
-0.690
0.490
Osteoporosis
History:
-1.7
0.4
-4.501
<0.001***
Psychological Condition
History:
-1.4
0.5
-2.690
0.007**
Chest Pain
ZIP-Level Median Income
0.1
0.0
2.481
0.013*
(per $10,000)
Adjusted R-squared 0.29, Root Mean Squared Error 13.0
Coefficients, Confidence Intervals (CIs), and Errors Rounded to 1 Decimal (except as noted)
*p<0.05 **p<0.01 ***p<0.001
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Figure 4.1: Histogram of Predicted Physical Therapy Visit Count by Inclusion Status

Figure 4.2: Histogram of Predicted MDQ Change by Inclusion Status

54

Chapter 5
Discussion & Concluding Remarks
Study Summary
The broad goals of these investigations were to use a single patient population
from a large, unified physical therapy provider to 1) identify the influence of patient
financial liability on visits and patient reported outcomes (PROs) and 2) analyze the
samples of included and excluded patients to establish an understanding of the
generalizability of the results to a broader patient population. An instrumental variable
(IV) regression approach was used to analyze Research Question 1. The IV, insurance
plan-level patient financial liability per visit, exhibited mediocre strength to differentiate
a marginal subset of patients for whom visit count was influenced by their willingness
and ability to pay for an additional physical therapy visit; however, the direction of the
effect was counter to stated theory. This is likely related to the lack of control for
individual-level socioeconomic status and plan structure. Recent evidence suggests that
patients with higher socioeconomic status self-select to high deductible plans and/or
plans that allow for health savings accounts as they are more comfortable taking on the
risk associated with healthcare cost.47,70 Despite the findings and lack of significance
observed in this study, there remains evidence in support of physical therapy as a low
risk, low cost intervention for patients with LBP. Denninger et al52 identified a cost
savings of nearly $1,600 per patient in the year following enrollment in a physical
therapy-first program that incentivized physical therapy visits with a $20 copayment per
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visit when compared against to those that followed the typical medical referral model that
was deductible and coinsurance-based. An earlier physical therapy-first study by Mitchell
and de Lissovoy90 identified similar cost savings of over $1200 per patient for patients
that sought physical therapy first over those following the traditional medical referral
path. Frogner et al91 identified lower out-of-pocket cost to the patient, lower probability
of opioid and advanced imaging utilization, and less emergency department utilization in
patients that saw a physical therapist for LBP as their first point of contact. Additional
evidence from Garrity et al47 concluded that unrestricted direct access to physical therapy
resulted in decreased health utilization and costs in patients with LBP. Finally, a 2019
systematic review by Arnold et al92 observed consistently lower utilization of health
services in patients that received early physical therapy for LBP relative to delayed
physical therapy or usual medical care. While indirectly related, insurance plans that
incentivize physical therapy (i.e., as described in Denninger et al52) might logically
expect a larger number of patients to seek physical therapy services early or first, rather
than delayed or not at all. While the results of Research Question 1 presented in Chapter
3 may appear to run counter to these studies, it is likely a function of missing and
unavailable patient information. Because individual level financial information likely
drives healthcare decisions more than population-based socioeconomic status (i.e., ZIPlevel median income) and average insurance-level financial liability per physical therapy
visit, our inability to control for individual socioeconomic status and health plan structure
significantly limit our ability to accurately execute the study.
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Generalizability and Limitations of Results
The comparison of patient cohorts that were included and excluded from the
primary study yielded few potentially clinically important differences. It was an expected
finding that visits differed between cohorts because many in this cohort lacked a followup MDQ, as the electronic health record prompts the physical therapy provider to seek
follow-up outcomes at specified visit (often 10 visits) or chronological (often 30 days)
increments. These patients lacking a follow-up MDQ might actually represent a
“marginal” population of patients that fail to continue their intended course of physical
therapy as a direct result of financial barriers. Unfortunately, we are left to compare their
baseline information and the 2 “index” measures with those included to determine a level
of generalizability to this group. Patient financial liability was only available on final
adjudicated and paid claims—not those that were still being pursued and negotiated.
Again, the patient population engaged in a lengthy collections process may further
represent patients for whom insurance-level patient financial liability may influence their
ability to fully participate in a physical therapy episode of care.
Finally, we are left to consider the effect of unexplained variance on the
generalizability of results. Available information explains less than 5% of the variability
in visits. It is likely that other clinical, financial, behavioral, and/or belief-related factors
that are currently unmeasured play a role in predicting visits and this unmeasured
confounding is a threat to generalizability. Similarly, with 24% of the variance explained
in the prediction of MDQ change, it is likely that some of these other unmeasured factors
influence MDQ change and make our results less generalizable. However, given all
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available information derived from these studies, we did not find any differences and are
comfortable with the generalizability of results.
Future Direction
Prior to moving toward manuscript publication, it is important to seek “better”
patient and insurance-level information. While individual socioeconomic status is likely a
large contributor in patients’ ability or inability to participate in complete physical
therapy episodes of care, a large, privately owned physical therapy provider will not
likely ever collect this information on a large scale. The only remaining possible data
refinement that can improve model performance and decreased unexplained variance is
acquisition of specific plan structure. Consistent with recent findings, it is our belief that
being able to control for information related to plan structure will significantly improve
model performance for regression models predicting physical therapy visit count.47
Related information including the use of capitation and/or requisite authorization would
further optimize the prediction of physical therapy visit count. Finally, future research
should further explore the interrelationship between personal factors, health insurance
plan structure, utilization of non-pharmacological guideline adherent interventions
(including physical therapy), and functional outcomes using a variety of research
methods. It will be vital to better understand these relationships as healthcare and
healthcare reimbursement models continue to evolve.
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